David Leppert, MSVirtual2020 – Potential of Neutrophil Granulocyte Markers in CSF to Differentiate NMOSD and MOGAD from MS
It was a pleasure to hear from David Leppert (University Hospital Basel and University of Basel, Basel, Switzerland) on his late-breaking presentation about the exciting potential of neutrophil granulocyte markers in the cerebrospinal fluid to differentiate neuromyelitis optica spectrum disorder (NMOSD) and myelin oligodendrocyte glycoprotein antibody disease (MOGAD) from multiple sclerosis (MS) in the acute disease phase. […]
Journal articles and more to your inbox
Get the latest clinical insights from touchIMMUNOLOGYSign me up!